Acme United (ACU) Q2 2026 Earnings Beat on MyMedic Integration and Margin Expansion

• Acme United Corporation (ACU) delivered second-quarter 2026 earnings that significantly exceeded analyst expectations, with EPS reaching $1.22 against a forecast of $0.81.
• Revenue hit $62.7 million versus $58.1 million estimated, driven by a 16% year-over-year sales increase fueled by the MyMedic acquisition and 8% organic growth.
• Gross margins expanded to 42.6% from 41.0% in the prior year, reflecting improved operational efficiency and easing tariff pressures.
• The stock surged nearly 12% on the news, approaching a 52-week high of $51.88, though elevated SG&A expenses remain a concern for long-term profitability.

Acme United Corporation (ACU) reported second-quarter 2026 earnings that significantly exceeded analyst expectations, with EPS reaching $1.22 against a forecast of $0.81 and revenue hitting $62.7 million versus $58.1 million estimated. The stock surged nearly 12% on the news, reflecting strong investor sentiment toward the company's operational turnaround and strategic acquisitions. Sales growth of 16% year-over-year was primarily fueled by the integration of MyMedic, while organic growth excluding acquisitions stood at 8%.

The performance was bolstered by a 16% year-over-year sales increase, which was bifurcated between a significant contribution from the MyMedic acquisition and 8% organic growth excluding acquisition effects. Profitability metrics improved notably, with gross margins expanding to 42.6% from 41.0% in the prior year period. CEO Johnsen provided forward-looking context, expecting continued margin recovery as the company navigates tariff impacts, noting that lower-cost inventory is currently replacing higher-tariff stock, a trend expected to persist through year-end.

How Did MyMedic Integration Drive Acme United's Growth?

The integration of MyMedic is progressing, with a strategic focus on expanding distribution beyond direct-to-consumer channels into mass retail. This expansion is critical for Acme United to diversify its revenue streams and reduce reliance on specific channels that may face volatility. The acquisition has contributed significantly to the 16% year-over-year sales increase, highlighting the success of the company's M&A strategy in capturing market share.

Management anticipates strong fourth-quarter profitability driven by seasonal demand, which is expected to further support revenue growth and margin expansion. The company's ability to successfully integrate MyMedic and expand its distribution network will be key indicators of future success, particularly as it seeks to capitalize on the growing demand for its medical and safety products.

What Are the Key Risks and Headwinds for ACU Investors?

Despite the positive results, investors should monitor several key risks, including high selling, general, and administrative (SG&A) expenses at 32% of sales. The company faces ongoing headwinds from tariffs, freight costs, and currency fluctuations, which could impact future profitability and operational efficiency. Geographic performance has been uneven, with the Canadian market lagging behind other regions, suggesting potential challenges in international expansion and market penetration.

Analyst coverage for Acme United remains limited, with Freedom Capital Markets maintaining a Buy rating and a $53 price target as of March 2026. This target implies a slight downside from current trading levels, suggesting limited near-term upside potential despite the positive rating. The consensus view reflects cautious optimism, but the lack of broad analyst coverage may lead to increased volatility and uncertainty for investors.

How Do Tariff Pressures and Inventory Cycles Impact Margins?

CEO Johnsen indicated that margin recovery is expected to continue as the company replaces higher-tariff inventory with lower-cost stock throughout the remainder of the year. This strategic inventory management is crucial for maintaining gross margin expansion and improving overall profitability, especially in a volatile trade environment. The easing of tariff pressures is a significant factor in the company's ability to sustain its improved margin performance, providing a clearer path to long-term financial stability.

The company's focus on operational efficiency and cost management will be essential in navigating these challenges and ensuring sustained growth, particularly as it continues to integrate new acquisitions and expand its market presence. Investors should closely monitor the company's quarterly reports for updates on tariff impacts, inventory levels, and SG&A expense trends to assess the sustainability of the current growth trajectory.